Vanguard Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.1M Buy
5,033,934
+162,869
+3% +$1.53M ﹤0.01% 2145
2025
Q1
$59.8M Sell
4,871,065
-10,903
-0.2% -$134K ﹤0.01% 2019
2024
Q4
$64.5M Sell
4,881,968
-5,006
-0.1% -$66.2K ﹤0.01% 2054
2024
Q3
$94.1M Buy
4,886,974
+89,885
+2% +$1.73M ﹤0.01% 1897
2024
Q2
$98.5M Sell
4,797,089
-129,895
-3% -$2.67M ﹤0.01% 1845
2024
Q1
$117M Buy
4,926,984
+591,631
+14% +$14.1M ﹤0.01% 1780
2023
Q4
$93.7M Buy
4,335,353
+718,051
+20% +$15.5M ﹤0.01% 1898
2023
Q3
$52.5M Buy
3,617,302
+34,632
+1% +$503K ﹤0.01% 2114
2023
Q2
$75M Buy
3,582,670
+85,585
+2% +$1.79M ﹤0.01% 2012
2023
Q1
$73.9M Buy
3,497,085
+133,635
+4% +$2.82M ﹤0.01% 1977
2022
Q4
$85.6M Buy
3,363,450
+561,151
+20% +$14.3M ﹤0.01% 1887
2022
Q3
$67.3M Buy
2,802,299
+21,396
+0.8% +$514K ﹤0.01% 2032
2022
Q2
$53.5M Buy
2,780,903
+348,465
+14% +$6.7M ﹤0.01% 2165
2022
Q1
$42.3M Buy
2,432,438
+95,068
+4% +$1.65M ﹤0.01% 2386
2021
Q4
$51.2M Buy
2,337,370
+167,964
+8% +$3.68M ﹤0.01% 2334
2021
Q3
$41.5M Buy
2,169,406
+60,658
+3% +$1.16M ﹤0.01% 2461
2021
Q2
$36.2M Buy
2,108,748
+37,800
+2% +$649K ﹤0.01% 2538
2021
Q1
$46.3M Buy
2,070,948
+219,115
+12% +$4.9M ﹤0.01% 2362
2020
Q4
$41.2M Buy
1,851,833
+454,748
+33% +$10.1M ﹤0.01% 2307
2020
Q3
$20.6M Sell
1,397,085
-35,455
-2% -$523K ﹤0.01% 2443
2020
Q2
$21.2M Buy
1,432,540
+353,812
+33% +$5.24M ﹤0.01% 2395
2020
Q1
$11.8M Buy
1,078,728
+9,141
+0.9% +$100K ﹤0.01% 2538
2019
Q4
$9.39M Sell
1,069,587
-2,561
-0.2% -$22.5K ﹤0.01% 2888
2019
Q3
$8.01M Buy
1,072,148
+42,998
+4% +$321K ﹤0.01% 2929
2019
Q2
$9.58M Buy
1,029,150
+80,761
+9% +$752K ﹤0.01% 2881
2019
Q1
$4.98M Buy
948,389
+99,747
+12% +$524K ﹤0.01% 3146
2018
Q4
$3.78M Buy
848,642
+112,038
+15% +$499K ﹤0.01% 3183
2018
Q3
$5.95M Sell
736,604
-26,336
-3% -$213K ﹤0.01% 3164
2018
Q2
$5.36M Buy
762,940
+18,996
+3% +$133K ﹤0.01% 3195
2018
Q1
$10.6M Buy
743,944
+53,062
+8% +$755K ﹤0.01% 2802
2017
Q4
$6.05M Buy
690,882
+87,103
+14% +$763K ﹤0.01% 3051
2017
Q3
$7.06M Buy
603,779
+91,155
+18% +$1.07M ﹤0.01% 2974
2017
Q2
$7.16M Buy
512,624
+102,700
+25% +$1.43M ﹤0.01% 2936
2017
Q1
$5.62M Buy
409,924
+19,522
+5% +$268K ﹤0.01% 3017
2016
Q4
$2.8M Buy
390,402
+97,478
+33% +$699K ﹤0.01% 3246
2016
Q3
$4.44M Buy
292,924
+123,023
+72% +$1.87M ﹤0.01% 3064
2016
Q2
$1.67M Buy
+169,901
New +$1.67M ﹤0.01% 3437